Literature DB >> 26182131

Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.

Tetsuro Sohda1, Hiroyuki Kusuhara2, Yoshiki Egashira2, Keisuke Egashira2, Koichi Eguchi3, Kunihiko Aoyagi3, Shotaro Sakisaka3.   

Abstract

A 67-year-old man was admitted to our hospital because of a large liver tumor revealed by ultrasonography. Laboratory data showed increased serum levels of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP), which are tumor markers for hepatocellular carcinoma. In addition, the serum cholesterol level was extremely high. Endoscopic examination revealed advanced gastric cancer. Histological findings of the stomach and liver tumor showed they were both hepatoid adenocarcinomas and were both positive for antibodies against AFP as well as DCP, suggesting that the tumors were gastric cancer with liver metastasis. Moreover, 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase, a key enzyme for regulation of cholesterol synthesis, was upregulated in the tumor tissues. Accordingly, we diagnosed this patient with AFP- and DCP-producing gastric cancer accompanied by paraneoplastic hypercholesterolemia. Paraneoplastic hypercholesterolemia is sometimes seen in hepatocellular carcinoma, but never in gastric cancer. This case is interesting because of the feature of hepatoid adenocarcinoma.

Entities:  

Keywords:  3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase; Alpha-fetoprotein (AFP); Des-gamma-carboxy prothrombin (DCP); Hepatoid adenocarcinoma; Hypercholesterolemia; Paraneoplastic syndrome

Year:  2013        PMID: 26182131     DOI: 10.1007/s12328-013-0420-z

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

1.  Hepatoid adenocarcinomas of the stomach. An analysis of seven cases.

Authors:  H Ishikura; K Kirimoto; M Shamoto; Y Miyamoto; H Yamagiwa; T Itoh; M Aizawa
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

2.  3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemia.

Authors:  Tetsuro Sohda; Kaoru Iwata; Genryu Hirano; Kunitoshi Sakurai; Keiji Yokoyama; Daisuke Morihara; Yasuaki Takeyama; Makoto Irie; Satoshi Shakado; Shotaro Sakisaka
Journal:  Med Mol Morphol       Date:  2013-04-03       Impact factor: 2.309

3.  Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.

Authors:  Tetsuro Sohda; Yoshitaka Tomioka; Shinjiro Inomata; Isamu Morita; Koichi Eguchi; Kunihiko Aoyagi; Hiroshi Watanabe; Shotaro Nakamura; Shotaro Sakisaka
Journal:  Intern Med       Date:  2005-04       Impact factor: 1.271

4.  3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer.

Authors:  Maria Gabriella Caruso; Maria Notarnicola; Aldo Cavallini; Alfredo Di Leo
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

5.  Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liver.

Authors:  Tetsuro Sohda; Takayuki Hanano; Hisanori Miyamoto; Yoko Kitano; Kaoru Iwata; Masanori Yokoyama; Makoto Irie; Yasuaki Takeyama; Satoshi Shakado; Shotaro Sakisaka
Journal:  Hepatol Int       Date:  2008-04-08       Impact factor: 6.047

6.  Hypercholesterolaemia in patients with hepatocellular carcinoma.

Authors:  S J Hwang; S D Lee; C F Chang; J C Wu; S H Tsay; W Y Lui; J H Chiang; K J Lo
Journal:  J Gastroenterol Hepatol       Date:  1992 Sep-Oct       Impact factor: 4.029

7.  Albumin gene expression in adenocarcinomas with hepatoid differentiation.

Authors:  M P Foschini; P Baccarini; P R Dal Monte; J Sinard; V Eusebi; J Rosai
Journal:  Virchows Arch       Date:  1998-12       Impact factor: 4.064

8.  Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.

Authors:  Y C Chang; N Nagasue; S Abe; H Taniura; D D Kumar; T Nakamura
Journal:  Am J Gastroenterol       Date:  1992-03       Impact factor: 10.864

9.  Reduced expression of low-density lipoprotein receptor in hepatocellular carcinoma with paraneoplastic hypercholesterolemia.

Authors:  Tetsuro Sohda; Kaoru Iwata; Yuji Kitamura; Norihisa Suzuki; Yasuaki Takeyama; Makoto Irie; Akira Anan; Hidetoshi Nakane; Makoto Yoshikane; Hiroshi Watanabe; Shotaro Sakisaka
Journal:  J Gastroenterol Hepatol       Date:  2007-09-03       Impact factor: 4.029

10.  Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.

Authors:  K R McIntire; T A Waldmann; C G Moertel; V L Go
Journal:  Cancer Res       Date:  1975-04       Impact factor: 12.701

View more
  3 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

2.  Life-threatening paraneoplastic cardiovascular events in ALK-positive anaplastic large cell lymphoma.

Authors:  Charlotte Verhaeghe; Björn Meijers; Ann Mertens; Peter R Sinnaeve; Sander Jentjens; Adinda Baten; F J Sherida H Woei-A-Jin
Journal:  Ann Hematol       Date:  2021-09-29       Impact factor: 3.673

Review 3.  Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuwen Zhou; Yuqing Wang; Jiaming Yuan; Xuelei Ma
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.